Search

Your search keyword '"Andrea, Doria"' showing total 1,953 results

Search Constraints

Start Over You searched for: Author "Andrea, Doria" Remove constraint Author: "Andrea, Doria"
1,953 results on '"Andrea, Doria"'

Search Results

1. Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort

2. Predictors of response to bDMARDs and tsDMARDs in psoriatic arthritis: a pilot study on the role of musculoskeletal ultrasound

Catalog

Books, media, physical & digital resources

3. COVID-19 vaccine and the risk of flares in inflammatory arthritis: a systematic literature review and meta-analysis

4. Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis

5. Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis

6. Fertility issues in women of childbearing age with spondyloarthritis

7. Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study

8. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committeeResearch in context

9. P138 Pregnancy outcomes in SLE patients treated with belimumab: the Italian experience

21. Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience.

22. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

23. Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study

25. Cutting-Edge Strategies for Renal Tumour-like Lesions in Granulomatosis with Polyangiitis: A Systematic Review

26. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort

27. The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort study

31. THz Data Analysis and Self-Organizing Map (SOM) for the Quality Assessment of Hazelnuts

32. Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial

33. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology

34. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies

36. Treatment management of patients with systemic lupus erythematosus: a delphi consensus analysis

37. Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study

38. Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort

39. Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients

40. Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis

41. Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study

42. Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis

44. Early Changes in B and Plasma Cell Subsets and Traditional Serological Markers as Predictors of SRI-4 Response to Therapy in Systemic Lupus Erythematosus

45. Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study

46. CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies

47. Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil

48. Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: a literature review

49. Adaptación y validación de la Escala de Prejuicio Sutil y Manifiesto hacia inmigrantes venezolanos en una muestra colombiana

50. The Genetic Contribution to Drug Response in Spondyloarthritis: A Systematic Literature Review